End-of-day quote
Other stock markets
|
||
- SEK | - |
Mar. 04 | Intervacc AB Announces Changes in the Nomination Committee | CI |
Feb. 28 | Intervacc's Acting CEO Assumes Role Permanently | MT |
Business Summary
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Novel Veterinary Vaccines
100.0
%
| 5 | 100.0 % | 10 | 100.0 % | +84.77% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 5 | 100.0 % | 10 | 100.0 % | +84.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jonas Sohlman
CEO | Chief Executive Officer | - | 23-08-20 |
Jan Persson
DFI | Director of Finance/CFO | - | 20-02-05 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-10 |
Patrik Hellberg
CIO | Chief Investment Officer | - | - |
Tim Wood
LAW | General Counsel | - | 18-07-31 |
Corporate Officer/Principal | 45 | 10-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Boel Sundvall
BRD | Director/Board Member | 65 | 22-12-31 |
Chairman | 56 | - | |
Edwin Torr
BRD | Director/Board Member | 63 | - |
Director/Board Member | 63 | 08-12-31 | |
Bengt Guss
FOU | Founder | 66 | 00-12-31 |
Niels Holcke
BRD | Director/Board Member | - | 19-12-31 |
Michela de Carli
BRD | Director/Board Member | - | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,736,264 | 59,198,500 ( 78.16 %) | 0 | 78.16 % |
Company contact information
Intervacc AB
Västertorpsvägen 135 Hägersten
129 44, Stockholm
+46 8 12 01 06 00
http://www.intervacc.comSector
1st Jan change | Capi. | |
---|---|---|
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- IVACC Stock
- Stock
- Company Intervacc AB